Evidence map›Paper›PMID 30254497›Full record

ReviewHepatic medicine : evidence and research2018

Acute pediatric hyperammonemia: current diagnosis and management strategies.

Nadia Savy, David Brossier, Catherine Brunel-Guitton, Laurence Ducharme-Crevier, Geneviève Du Pont-Thibodeau, Philippe Jouvet

Abstract readReview
In one paragraph

Review in Hepatic medicine : evidence and research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Observational
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. [Interpretation of the "Expert consensus on the diagnosis and treatment of neonatal hyperammonemia"].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nadia SavyDepartment of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada, philippe.jouvet@umontreal.ca.
David BrossierDepartment of Pediatrics, Pediatric Intensive Care Unit, CHU Caen, Caen, France.
Catherine Brunel-GuittonDepartment of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada, philippe.jouvet@umontreal.ca.
Laurence Ducharme-CrevierDepartment of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada, philippe.jouvet@umontreal.ca.
Geneviève Du Pont-ThibodeauDepartment of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada, philippe.jouvet@umontreal.ca.
Philippe JouvetDepartment of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada, philippe.jouvet@umontreal.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute hyperammonemia may induce a neurologic impairment leading to an acute life-threatening condition. Coma duration, ammonia peak level, and hyperammonemia duration are the main risk factors of hyperammonemia-related neurologic deficits and death. In children, hyperammonemia is mainly caused by severe liver failure and inborn errors of metabolism. In an acute setting, obtaining reliable plasma ammonia levels can be challenging because of the preanalytical difficulties that need to be addressed carefully. The management of hyperammonemia includes 1) identification of precipitating factors and cerebral edema presence, 2) a decrease in ammonia production by reducing protein intake and reversing catabolism, and 3) ammonia removal with pharmacologic treatment and, in the most severe cases, with extracorporeal therapies. In case of severe coma, transcranial Doppler ultrasound could be the method of choice to noninvasively monitor cerebral blood flow and titrate therapies.

Indexed as

critical carehemodialysishyperammonemiapediatricssodium benzoatesodium phenylacetate

Identifiers

PMID30254497
PMCPMC6140721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.